by In2Pharma | Dec 12, 2018 | News
EU Versions 11 & 12 of the Q&A on Safety features for medicinal products for human use have been published in October and November of 2018. Following these updates, multiple questions have been revised (1.20; 1.23; 2.21; 7.15; 8.4; 8.7) and some new questions...
by In2Pharma | Sep 12, 2017 | News
FAMHP Recently, FAMHP published guidelines as well as Q&A documents related to the Falsified Medicines Directive. No later than 9 February 2019, safety features as imposed by the Falsified Medicines Directive 2011/62/EU of the European Parliament and of the...
